Expression of angiotensin II type 1 receptor in human cirrhotic livers: Its relation to fibrosis and portal hypertension.

Expression of angiotensin II type 1 receptor in human cirrhotic livers: Its relation to fibrosis and portal hypertension. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Expression of angiotensin II type 1 receptor in human cirrhotic livers: Its relation to fibrosis and portal hypertension. Abstract Text:

Yoshihiro Ikura,Masahiko Ohsawa,Nobuyuki Shirai,Yoshimi Sugama,Hiroko Fukushima,Takehisa Suekane,Michihiko Hirayama,Shoichi Ehara,Takahiko Naruko,Makiko Ueda,

Angiotensin II (ANG-II) and its receptor (AT1) have been potential targets of therapy for liver cirrhosis. However, AT1 expression in human cirrhotic livers has not been clarified. We studied AT1 and ANG-II generating enzymes in human autopsy (20 cirrhotics and 20 normal controls) and biopsy (10 cirrhotics) livers. AT1 immunoreactivity in tissue sections was quantified by computer-aided morphometry. AT1 protein and mRNA levels were assessed by Western blotting and real-time polymerase chain reaction. Concerning ANG-II generating system, angiotensin-converting enzyme (ACE) and mast cell chymase were examined. AT1 expression was seen not only in vascular smooth muscle cells, but also in activated stellate cells/myofibroblasts and liver parenchymal cells. AT1-positive vessels and myofibroblasts were significantly increased in fibrous septa of cirrhosis, although overall hepatic AT1 expression was reduced in the cirrhotic livers compared with the controls. Augmentation of AT1-positive vessels was related to severity of portal hypertension. Expressions of ACE and chymase were enhanced in the cirrhotic livers. These results suggest that hepatic AT1 expression is shifted to and concentrated in vessels and myofibroblasts in cirrhotic settings, and increased ANG-II generation by ACE and chymase contributes to portal hypertension and liver fibrosis via binding to AT1 expressed on vessels and myofibroblasts.

Expression of angiotensin II type 1 receptor in human cirrhotic livers: Its relation to fibrosis and portal hypertension. Publishing Authors By Initials

Y Ikura,M Ohsawa,N Shirai,Y Sugama,H Fukushima,T Suekane,M Hirayama,S Ehara,T Naruko,M Ueda,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Expression of angiotensin II type 1 receptor in human cirrhotic livers: Its relation to fibrosis and portal hypertension. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Hepatology research : the official journal of the

VOLUME: 32

Page Numbers: 107-16

Journal Abbreviation:

ISSN: 1386-6346

DAY: 7

MONTH: Jun

YEAR: 2005

Expression of angiotensin II type 1 receptor in human cirrhotic livers: Its relation to fibrosis and portal hypertension. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9711801

Expression of angiotensin II type 1 receptor in human cirrhotic livers: Its relation to fibrosis and portal hypertension. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Expression of angiotensin II type 1 receptor in human cirrhotic livers: Its relation to fibrosis and portal hypertension. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Expression of angiotensin II type 1 receptor in human cirrhotic livers: Its relation to fibrosis and portal hypertension.

AFFILIATION: Department of Pathology, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan.

Country: Netherlands

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Hepatol Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Expression of angiotensin II type 1 receptor in human cirrhotic livers: Its relation to fibrosis and portal hypertension Related Publications

• A functional genomics strategy reveals clockwork orange as a transcriptional regulator in the Drosophila circadian clock.
• Analyses of native disulfide bond formations in the early stage of the folding process in mutant lysozymes where the long-range interactions in the denatured state were modulated.
• Clinical characteristics of bicuspid aortic valves in surgical patients.
• Construction of a novel synergistic system for production and recovery of secreted recombinant proteins by the cell surface engineering.
• Differential effects of heterocyclic amines on poly(ADP-ribose) polymerase-1 and mono-ADP-ribosyltransferase A.
• Differential inducibility of human and porcine dental pulp-derived cells into odontoblasts.
• Drug-induced hypersensitivity syndrome associated with a marked increase in anti-paramyxovirus antibody titers in a scleroderma patient.
• Dynamics of traveling pulses in heterogeneous media.
• Effective bone engineering with periosteum-derived cells.
• Enhancement of substrate recognition ability by combinatorial mutation of beta-glucosidase displayed on the yeast cell surface.
• Expression of PIN and AUX1 genes encoding putative carrier proteins for auxin polar transport in etiolated pea epicotyls [correction of epicotyles] under simulated microgravity conditions on a three-dimensional clinostat.
• Expression of angiotensin II type 1 receptor in human cirrhotic livers: Its relation to fibrosis and portal hypertension.
• Graviresponse and its regulation from the aspect of molecular levels in higher plants: growth and development, and auxin polar transport in etiolated pea seedlings under microgravity.
• Hemodynamic effects of dexmedetomidine in patients after cardiac surgery.
• High-power self-mode-locked Yb:Y(2)O(3) ceramic laser.
• Initial impact of drug-eluting stents on coronary artery bypass grafting.
• Ionization of linear alcohols by strong optical fields.
• Late mortality and morbidity in elderly patients with mechanical heart valves.
• Maxillary sinus floor augmentation in rabbits: a comparative histologic-histomorphometric study between rhBMP-2 and autogenous bone.
• Mitral valve surgery for dilated cardiomyopathy with mitral regurgitation.
• Odontoblast marker gene expression is enhanced by a CC-chemokine family protein MIP-3alpha in human mesenchymal stem cells.
• Prothymosin-alpha1 prevents necrosis and apoptosis following stroke.
• Reliability and reproducibility of vertical diffusion cells for determining release rates from semisolid dosage forms.
• Responsiveness of rabbits to superovulation treatment by a single injection of follicle-stimulating hormone with aluminum hydroxide gel.
• Ribosomal P protein P0 as a candidate for the target antigen of anti-endothelial cell antibodies in mixed connective tissue disease.
• Right ventricular end-diastolic volume in the postoperative care of cardiac surgery patients: a marker of the hemodynamic response to a fluid challenge.
• Sphingomonas astaxanthinifaciens sp. nov., a novel astaxanthin-producing bacterium of the family Sphingomonadaceae isolated from Misasa, Tottori, Japan.
• The sock method for a distal ascending aneurysm.
• What factors influence the results of coronary artery bypass grafting in aged patients?
• [A systems-biological approach in drug discovery for circadian rhythm disorders]